O

OptiNose

166 employees

OptiNose develops nasal drug delivery technologies and combined drug and device therapies.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Medical Device
Specialty Pharmaceuticals
ENT Therapy
Ear Nose Throat
Allergy Therapy
Pharmaceutical
Drug Development

Date founded

2010

Funding rounds raised

Total raised

$150M

from 10 investors over 10 rounds

O

OptiNose raised $150M on September 12, 2020

Investors: Pharmakon Advisors, LP

O

OptiNose raised $100M on January 2, 2018

Investors: Athyrium Capital Management, LP

O

OptiNose raised $37M on May 9, 2017

Investors: Avista Capital Partners and Entrepreneurs Fund

O

OptiNose raised $30M on October 6, 2015

Investors: The Entrepreneurs' Fund and Avista Capital Partners

O

OptiNose raised $35M on August 5, 2014

Investors: Avista Capital Partners and Entrepreneurs Fund

O

OptiNose raised $49M on June 7, 2010

Investors: Avista Capital Partners

O

OptiNose raised $935K on December 14, 2002

Investors: Oxygen House Group

FAQ